Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
29.39
+0.08 (0.27%)
At close: Jul 28, 2026, 4:00 PM EDT
29.39
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:15 PM EDT

Stoke Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-169.77-6.89-88.98-104.7-101.07-85.81
Depreciation & Amortization
1.731.772.182.471.550.97
Stock-Based Compensation
34.2432.2427.4725.2622.8516.45
Other Adjustments
1.412.120.621.941.781.43
Change in Receivables
--4.27-0.05---
Changes in Accounts Payable
0.8321.293.09-3.21-3.532.9
Changes in Unearned Revenue
-11.75-0.13-29.39-3.3551.74-
Changes in Other Operating Activities
-1.58-0.55-1.790.53-5.18-2.85
Operating Cash Flow
-146.8245.59-86.85-81.07-31.87-66.91
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.87-0.67-0.2-1.62-3.96-1.2
Purchases of Investments
-313.56-322.72-167.27--201.32-87.23
Proceeds from Sale of Investments
164.68136.5860107.56159.412
Investing Cash Flow
-149.75-186.81-107.48105.95-45.88-76.43

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
11.997.39131.0953.0146.411.29
Net Common Stock Issued (Repurchased)
11.997.39131.0953.0146.411.29
Other Financing Activities
----0-0
Financing Cash Flow
180.3497.39131.0953.0146.411.28

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-116.23-43.84-63.2377.89-31.34-142.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-147.744.92-87.05-82.68-35.83-68.11
Free Cash Flow Growth
------
FCF Margin
-460.40%24.35%-238.15%-941.72%-288.82%-
Free Cash Flow Per Share
-2.440.76-1.61-1.88-0.92-1.85
Levered Free Cash Flow
-181.4114.83-115.1-109.88-60.46-85.99
Unlevered Free Cash Flow
-195.51.12-127.49-119.95-63.75-86.25
SEC Filings: 10-K · 10-Q